AI
AMGN icon

AXS Investments’s Amgen AMGN Stock Holding History

AXS Investments’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.3K Sell
89
-26
-23% -$9.27K 0.01% 172
2025
Q4 		$37.6K Sell
115
-35
-23% -$11.1K 0.01% 178
2025
Q3 		$42.3K Buy
+150
New +$43.5K 0.01% 181
2025
Q2 		– Sell
-4,290
Closed -$1.34M – 150
2025
Q1 		$1.34M Sell
4,290
-769
-15% -$227K 0.37% 113
2024
Q4 		$1.32M Buy
5,059
+1,148
+29% +$341K 0.37% 121
2024
Q3 		$1.26M Sell
3,911
-39
-1% -$12.8K 0.33% 162
2024
Q2 		$1.23M Sell
3,950
-788
-17% -$231K 0.34% 118
2024
Q1 		$1.35M Buy
4,738
+105
+2% +$30.7K 0.32% 107
2023
Q4 		$1.33M Sell
4,633
-227
-5% -$61.9K 0.32% 121
2023
Q3 		$1.31M Buy
4,860
+4,733
+3,727% +$1.18M 0.34% 83
2023
Q2 		$28.2K Sell
127
-24
-16% -$5.57K 0.01% 369
2023
Q1 		$36.5K Buy
151
+25
+20% +$6.14K 0.01% 319
2022
Q4 		$33.1K Buy
+126
New +$33.8K 0.01% 303

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AXS Investments's AMGN Position: Q1 2026 in Review

AXS Investments reduced its Amgen (AMGN) stake by 23% in Q1 2026, selling an estimated $9.27K and leaving 89 shares worth $31.3K. The position accounts for 0.01% of the portfolio, ranked #172.

AXS Investments first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.35M in Q1 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AXS Investments held 89 shares of Amgen worth $31.3K as of Q1 2026.
  • AXS Investments sold 26 Amgen shares in Q1 2026, an estimated $9.27K.
  • Amgen made up 0.01% of AXS Investments's portfolio in Q1 2026, its #172 holding.
  • AXS Investments first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
  • AXS Investments's Amgen position peaked at $1.35M in Q1 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AXS Investments's 13F filing for Q1 2026, filed 6 May 2026.